Zhang W, Carmichael J, Ferguson J, Inglis S, Ashrafian H, Stanley M
Department of Pathology, University of Cambridge, United Kingdom.
Virology. 1998 Apr 10;243(2):423-31. doi: 10.1006/viro.1998.9050.
Major capsid protein L1 of HPV16 was produced in a fused form in Escherichia coli using an inducible expression system. The protein formed insoluble aggregations (inclusion bodies) and the yield was more than 10% of total cell proteins. The inclusion bodies were isolated and solubilised with 8 M urea and the L1 proteins were purified by chromatographic separation. Following removal of the urea by gradual dialysis, the denatured L1 proteins spontaneously renatured and subsequently assembled into polymorphologic aggregations in vitro. Electron microscopy showed that the assembled material included structures resembling native empty capsids as well as incompletely formed capsids. After separation from the pool of polymorphologic structures by sucrose gradient sedimentation, the correctly formed virus-like particles (VLE. coliPs) were recognised by a HPV16 type-specific, conformational-dependent monoclonal antibody in an ELISA. This system offers not only a model for investigation of the intrinsic interactions that occur during L1 assembly, but also a potential route for convenient manufacture of highly purified VLP vaccines.
人乳头瘤病毒16型(HPV16)的主要衣壳蛋白L1通过诱导表达系统在大肠杆菌中以融合形式产生。该蛋白形成不溶性聚集体(包涵体),产量超过总细胞蛋白的10%。分离包涵体并用8M尿素溶解,通过色谱分离纯化L1蛋白。通过逐步透析去除尿素后,变性的L1蛋白自发复性,随后在体外组装成多形态聚集体。电子显微镜显示,组装后的物质包括类似天然空衣壳的结构以及未完全形成的衣壳。通过蔗糖梯度沉降从多形态结构池中分离后,正确形成的病毒样颗粒(VLP)在ELISA中被HPV16型特异性、构象依赖性单克隆抗体识别。该系统不仅为研究L1组装过程中发生的内在相互作用提供了一个模型,也为方便生产高度纯化的VLP疫苗提供了一条潜在途径。